Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 15 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-15-2023-1

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 15, 2023, titled "Zydus receives final approval from the USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

In the deck

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases